Anti‐αLβ2 antibodies reveal novel endocytotic cross‐modulatory functionality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti‐αLβ2 antibodies reveal novel endocytotic cross‐modulatory functionality

Published:2020-03-09 Issue:12 Volume:177 Page:2696-2711
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Mancuso Riccardo V.¹²^ORCID,Casper Jens¹²,Schmidt Albrecht G.³,Krähenbühl Stephan¹²⁴,Weitz‐Schmidt Gabriele¹²³

Affiliation:

1. Division of Clinical Pharmacology & ToxicologyUniversity Hospital Basel Basel Switzerland

2. Department of BiomedicineUniversity of Basel Basel Switzerland

3. AlloCyte Pharmaceuticals AG Basel Switzerland

4. Swiss Centre for Applied Human Toxicology (SCAHT) Basel Switzerland

Funder

Innosuisse - Schweizerische Agentur für Innovationsförderung

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14996

Reference66 articles.

1. Therapeutic integrin inhibition: Allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

3. Distinct Recycling of Active and Inactive β1 Integrins

4. Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis

5. Integrins in T Cell Physiology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Flow Cytometry-Based High-Throughput Technique for Screening Integrin-Inhibitory Drugs;Journal of Visualized Experiments;2024-02-02

2. Decrypting Integrins by Mixed-Solvent Molecular Dynamics Simulations;Journal of Chemical Information and Modeling;2023-06-13

3. Allosteric targeting resolves limitations of earlier LFA-1 directed modalities;Biochemical Pharmacology;2023-05

4. T-Cell Adhesion in Healthy and Inflamed Skin;JID Innovations;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3